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Abstract
Objectives: To describe the epidemiology of 
pertussis, and to identify changes in the source of 
pertussis in infants 6 months of age and under, 
during the 2008–2012 epidemic in south metro-
politan Perth.
Design and setting: Analysis of all pertussis cases 
notified to the South Metropolitan Population 
Health Unit and recorded on the Western Australian 
Notifiable Infectious Disease Database over the 
study period. Information on the source of pertus-
sis was obtained from enhanced surveillance data.
Results: Notification rates were highest in the 
5–9 years age group, followed by the 0–4 years 
and 10–14 years age groups. There was a signifi-
cant increase in the proportion of known sources 
who were siblings from the early epidemic period 
of 2008–2010, compared with the peak epidemic 
period of 2011–2012 (14.3% versus 51.4%, 
p = 0.002). The majority of sibling sources were 
fully vaccinated children aged 2 and 3 years.
Conclusions: The incidence of pertussis was high-
est in children aged 12 years and under in this epi-
demic. At its peak, siblings were the most impor-
tant sources of pertussis in infants 6 months and 
younger, particularly fully vaccinated children aged 
2 and 3 years. Waning immunity before the booster 
at 4 years may leave this age group susceptible 
to infection. Even if cocooning programs could 
achieve full vaccination coverage of parents and 
ensure all siblings were fully vaccinated according 
to national schedules, waning immunity in siblings 
could provide a means for ongoing transmission 
to infants. Recent evidence suggests that maternal 
antenatal vaccination would significantly reduce 
the risk of pertussis in infants 3 months of age and 
under. Commun Dis Intell 2014;38(3):E195–E200.
Keywords: pertussis, whooping cough, infants, 
source, vaccination, immunisation
Introduction
The incidence of pertussis (whooping cough) has 
risen both in Australia and internationally over 
recent years, and large epidemics have occurred.1,2 
Increased clinician awareness and laboratory test-
ing are likely to be partially responsible for the 
apparent increase in disease incidence.3 However, 
the epidemiology of pertussis in Australia and 
the United States of America has also changed 
in recent times, with an increasing proportion of 
disease occurring in children.4–7 Possible reasons 
for this include the increasing use of less effective 
acellular vaccines8–10 and increasing circulation 
of Bordetella pertussis strains deficient of vaccine 
antigen.11,12 Within vaccinated populations, the 
fewer whole cell vaccines received, the greater the 
risk of pertussis.8,10 Additionally, immunity from 
acellular pertussis vaccination wanes more rapidly 
than that from whole cell vaccination.13–15 Pertussis 
morbidity and mortality are greatest in infants 
under the age of 6 months, who are too young to 
have completed a primary vaccination course. The 
implications of these changes for the source of 
infant pertussis remain unclear.
Household contacts are the most likely sources of 
infant pertussis, but there is variation in the propor-
tion of sources reported to be parents as opposed 
to siblings. A recently published Australian review 
on infant pertussis sources reported the source as 
a parent in 55% (range 39%–57%) and a sibling in 
16%–43%.16 The proportion of sources that were 
siblings varied widely between studies, in com-
parison to the proportion that were parents, which 
were more consistent. The conclusion was that 
siblings may be more important sources of infant 
pertussis than previously realised.16
A prolonged outbreak of pertussis occurred in 
Australia, including south metropolitan Perth, 
between 2008 and 2012. A cocooning strategy 
involving the vaccination of caregivers of newborns 
was implemented in Western Australia and ran for 
2011 and 2012 in attempts to protect newborns 
during the outbreak. This strategy can only be 
effective if caregivers are the main source of per-
tussis in infants.
Over the study period, the South Metropolitan 
Population Health Unit (SMPHU) collected 
enhanced surveillance data for pertussis cases in 
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children under 5 years of age. These data are not 
collected or reported at the national level so provide 
valuable additional information, particularly regard-
ing source of infection, to that routinely collected 
for the National Notifiable Diseases Surveillance 
System. This study aimed to describe the epidemi-
ology of the epidemic in south metropolitan Perth 
in relation to the source of infant pertussis, as well 
as any changes in the epidemiology and the source 
that occurred over the 5-year period.
Methods
The SMPHU is responsible for the follow up 
of notifiable diseases for the area covered by the 
South Metropolitan Health Service, which spans 
all of metropolitan Perth south of the Swan River 
and services approximately 37% of the Western 
Australian population.17 Over the study period, 
the SMPHU collected enhanced surveillance data 
for pertussis cases in children under 5 years of age. 
The process involves a trained public health nurse 
interviewing the treating doctor and caregiver of 
the notified case, in order to obtain further infor-
mation such as the likely source of infection and any 
high risk contacts. Enhanced surveillance defines 
a source of pertussis as a contact of the notified 
case who had either prolonged coughing illness 
or known pertussis infection, who was in contact 
with the notified case during the latter’s incuba-
tion period (from 6 to 21 days prior to symptom 
onset). In the case of multiple possible sources, the 
source was assumed to be the individual who first 
became symptomatic, provided that the source’s 
infectious period coincided with the notified case’s 
incubation period.
Enhanced surveillance data for notified cases in 
infants 6 months of age and under were examined 
retrospectively, as well as pertussis notification data 
recorded on the Western Australian Notifiable 
Infectious Disease Database (WANIDD) for all age 
groups. All confirmed and probable cases meeting 
the case definition for pertussis were included if 
the optimal date of onset of pertussis occurred any 
time from 1 January 2008 to 31 December 2012, 
and residential postcode was within the SMPHU 
catchment area. The optimal date of onset refers to 
the earliest date recorded on WANIDD reflecting 
disease onset. In some situations, such as those 
where the caregiver of the notified case could not 
be contacted by telephone, enhanced surveillance 
data were not available. Notified cases and sources 
were defined as being fully vaccinated for age if 
on the optimal date of onset of illness they had 
received all pertussis vaccinations recommended 
by the Western Australian immunisation sched-
ule for their age. This would potentially include 
vaccinations given within the 14 days preceding 
disease onset. The dates of vaccination for the 
source were not available so any such cases would 
be misclassified as being fully vaccinated for age at 
disease onset. Notified cases from the 2008–2010 
and 2011–2012 periods were compared because 
this distinction allowed comparison of the pre-
cocooning period with the cocooning period, and 
the early epidemic period with the peak epidemic 
period. Differences in age specific risk of infection 
as well as source of infant pertussis in the 2 periods 
were assessed.
Denominator data for notification rates were 
obtained from the Epidemiology Branch of the 
WA Department of Health. All analyses were 
performed in SPSS version 21. All comparisons 
were performed using chi-squared analyses or 
Fisher’s exact test for categorical variables, and 
Mann-Whitney U testing for continuous variables. 
The study was approved by the Curtin University 
Human Research Ethics Committee (protocol 
approval SPH-16-2013). Ethics approval was not 
sought elsewhere, as this study formed part of the 
core business of the SMPHU.
Results
There were 3,611 cases of pertussis notified to 
the SMPHU from 2008 to 2012, with this period 
demonstrating a dramatic increase in notifications 
in comparison with previous years (Figure 1). Of 
these cases, 37.3% (n = 1348) occurred in children 
12 years of age or under. At the peak of the epi-
demic in the December 2011 quarter, notification 
rates were markedly higher in children in age 
categories 14 years of age and under in comparison 
with the remainder of the population (Figure 1, 
Figure 2). The notification rate for the 5–9 years 
age group in the December 2011 quarter was 
341.4 per 100,000, and 243.0 per 100,000 for the 
10–14 years age group. Notification rates peaked 
in adults in this quarter also, but the amplitude of 
the peak was much less marked (56.0 per 100,000). 
Notification rates in children 4 years of age and 
under did not peak until the following quarter, at 
206.8 per 100,000.
Of the 115 cases of pertussis in infants 6 months 
of age and under, enhanced surveillance data were 
available for 106 (92.2%). The optimal date of onset 
was the date of symptom onset for 111 of 115 cases, 
and the laboratory specimen date for the remain-
ing four. There were no significant differences 
between those who had undergone enhanced sur-
veillance and those who had not, comparing gen-
der (p = 0.74), age (p = 0.56), ethnicity (p = 1.00) 
and hospitalisation status (p = 0.48).
The source was identified in 65 of 106 cases (61.3%). 
Two potential sources were identified for two of 
these cases, and one for the remaining 104 cases. 
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The proportion of sources whose diagnosis was 
confirmed with laboratory testing was unknown. 
Over the 5-year period, the source was a parent 
in 38.5% (n = 25) of cases and a sibling in 35.4% 
(n = 23) of cases. The most likely source of per-
tussis differed in the 2008–2010 period compared 
with the 2011–2012 period (Table). The proportion 
of parents as a source was lower in the 2011–2012 
period (32.4%, n = 12 versus 46.4%, n = 13). 
However this difference was not statistically sig-
nificant (p = 0.25). In contrast, the proportion of 
sources that were siblings was significantly higher 
in the 2011–2012 period (51.4%, n = 19 versus 
14.3%, n = 4; p = 0.002).
During the 2011–2012 peak epidemic period, 
the ages of 14 of 19 sibling sources were known. 
Eight of these sources were aged from 2 to 4 years 
with five being fully vaccinated, one partially vac-
cinated, one unvaccinated, and one of unknown 
vaccination status. The true number of children 
in the 2–4 years age group may have been higher 
as the ages of 5 children were not recorded. Three 
sources were aged 6–11 years, and three were aged 
12–19 years. Of all children in south metropolitan 
Perth diagnosed with pertussis in 2008–2012 and 
aged from 7 months to 4 years, 78.1% (n = 267) 
were fully vaccinated for age.
Discussion
Recent studies have shown an increasing incidence 
of pertussis in children but the implications of this 
for the source of infant pertussis have not been 
fully described. Identifying the source of pertussis 
in infants 6 months of age and under is crucial for 
the development of effective preventive strategies 
in this age group. However, the most likely source 
of infection will reflect local epidemiology, and if 
Figure 1: Notification rates of pertussis, south 
metropolitan Perth, 2008 to 2012, by quarter 
and age group
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Figure 2: Notification rate of pertussis, south 
metropolitan Perth, 2008 to 2010 compared 
with 2011 to 2012, by age group
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Table: Source of pertussis in infants 6 months of age and under, south metropolitan Perth, 2008 
to 2010 compared with 2011 to 2012
2008-2010 2011-2012 Total
n
Known 
source 
%
Notified 
cases 
% n
Known 
source 
%
Notified 
cases 
% n
Known 
source 
%
Notified 
cases 
%
Parent 13 46.4 24.5 12 32.4 19.4 25 38.5 21.7
Sibling 4 14.3 7.5 19 51.4 30.6 23 35.4 20
Other household contact 3 10.7 5.7 2 5.4 3.2 5 7.6 4.3
Grand parent 3 10.7 5.7 3 8.1 4.8 6 9.2 5.2
Cousin 3 10.7 5.7 0 0 0 3 4.6 2.6
Other household contact 2 7.1 3.8 1 2.7 1.6 3 4.6 2.6
Total known source 28 37 65
Notified cases with available 
enhanced surveillance data
45 61 106
Notified cases 6 months of 
age and under
53 62 115
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the age specific risk of infection changes during 
epidemics, the source of pertussis in infants could 
vary at different points in the epidemic cycle. This 
study demonstrates changes in the source of infant 
pertussis corresponding with changing age specific 
risk of infection during an epidemic period.
Notification rates were highest in children in this 
epidemic, particularly at its peak in the 2011–2012 
period. This correlated with a dramatic rise in the 
proportion of sibling sources. There are several 
possible explanations for the high notification rates 
in children. Recent studies suggest that acellular 
pertussis vaccine immunity wanes more rapidly 
than that of the whole cell pertussis vaccine.8,10,13–15 
The vaccine effectiveness of the whole cell pertus-
sis vaccine previously administered in Australia 
was estimated at 91% (95% CI 85.5%–94.4%) 
in infants aged 8–23 months, and 84.5% (95% 
CI 78.3%–88.9%) in the 2–4 years age group.19 
In contrast, a recent Australian study reported 
the vaccine effectiveness of acellular vaccine to 
be 83.5% (95% CI 79.1%–87.8%) in infants aged 
6–11 months, falling to 70.7% (95% CI 64.5%–
75.8%) in children aged 2 years, and 59.2% (95% 
CI 51.0%–66.0%) in children aged 3 years.20 In 
the whole cell pertussis vaccine effectiveness study, 
children had received 5 doses of pertussis vaccine 
by age 5 (2, 4, 6, 18 months and 4 years). In con-
trast, the acellular pertussis vaccine effectiveness 
for the children aged 2 and 3 years was calculated 
for children receiving 3 doses of vaccine, reflecting 
the current pertussis vaccination schedule of 2, 4, 
6 months and 4 years.20
The high notification rates in children and the 
higher percentage of sibling sources could also be 
epidemic specific features, given the timing of this 
study. This is feasible as studies of contact patterns 
have shown high levels of assortative mixing in 
children.21 Age specific infection risk and infant 
pertussis source types may be different in the 
inter-epidemic period. This would be congruent 
with the findings of this study, given that propor-
tions of sources that were parents and siblings in 
the 2008–2010 period were comparable with those 
reported in previous literature.16 Even if high inci-
dence of pertussis in children and high proportions 
of siblings as sources are purely epidemic specific 
features, there are still implications for infant per-
tussis control measures during epidemics.
Cocooning programs are challenging to imple-
ment and there is no definitive evidence that they 
are successful in reducing the incidence of infant 
pertussis.22,23 Parents remain susceptible to per-
tussis for 14 days following immunisation, due to 
the time taken to mount an immune response.24 
The earlier parental immunisation is performed 
post-natally, the better protected infants will be, 
making hospital-based vaccination ideal. Barriers 
to this have been identified, including legal issues 
related to vaccinating fathers (who are not hospital 
patients), and the need to provide after-hours ser-
vices.25 In Western Australia in 2011, an estimated 
60% of mothers and 41% of fathers of newborns 
had been administered government funded pertus-
sis vaccine, although the timing of this vaccination 
post-natally is unknown (2012 data not available at 
the time of publication).26 These rates were similar 
to coverage rates reported in Victoria for the dura-
tion of their state wide cocooning program, where 
it was found that of those eligible, 68% of mothers 
and 49% of fathers were vaccinated.22 In metro-
politan areas of Victoria, 6% of mothers and 10% of 
fathers were vaccinated in the maternity hospital, 
compared with 70% of mothers and 42% of fathers 
in rural areas, suggesting that (particularly in 
metropolitan areas) vaccination may not have been 
given early enough in the neonatal period.22 In 
this study, although the proportion of sources that 
were parents was lower in the cocooning period 
(2011–2012) compared with the pre-cocooning 
period (2008–2010), this observation did not reach 
statistical significance. While this may be a real 
finding, there were insufficient numbers in this 
study to determine that. If the difference in the 
proportion of source cases that were parents in 
the 2 periods were real, cocooning may explain 
this reduction, but it is likely to be insufficient to 
explain the observed increase in the proportion of 
sibling sources.
The increasing proportion of sibling sources 
over time reflected the increasing proportion of 
pertussis notifications in children 12 years of age 
and under over the 2008–2012 epidemic. In the 
peak epidemic period, sibling sources of infec-
tion were most likely to be aged 2 or 3 years. This 
suggests that the impact of high notification rates 
was greatest in the youngest siblings, despite the 
greatest numbers of cases occurring in children 
aged 7–11 years. Possible reasons for this include 
that siblings tend to be close in age, and that 
younger children are generally less able to con-
trol respiratory secretions. The only other recent 
Australian study of infant pertussis sources had 
similar findings, demonstrating that siblings aged 
3 and 4 years were particularly important sources 
of infant pertussis during the 2009 epidemic in 
New South Wales.27 Dutch research published in 
2010 speculated that the high proportion of infant 
pertussis sources that were siblings (41%) in their 
study may have been related to the introduction 
of acellular pertussis vaccine in the Netherlands, 
as well as prior use of a less effective whole cell 
vaccine.24 In that study, the source was a sibling 
aged 1–4 years in 18% of cases (95% CI 12%–25%), 
a sibling aged 5–8 years in 15% of cases (95% 
CI 9%–21%), and a sibling aged 9–13 years in 
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8% of cases (95% CI 4%–13%). The vaccination 
schedule for that population involved vaccination 
at 2, 3, 4 and 11 months, with a booster at 4 years 
introduced 5 years prior to the commencement of 
the study. There is a possibility that with the intro-
duction of acellular pertussis vaccine, the interval 
between primary vaccination and booster doses in 
both the Dutch and Australian populations is now 
too long, resulting in waning immunity before the 
booster at 4 years. Even if all household contacts 
of newborns (including siblings) could be routinely 
fully vaccinated, the issue of breakthrough disease 
prior to the booster at 4 years would leave a certain 
proportion of siblings as possible infant pertussis 
sources, limiting the effectiveness of cocooning.
Vaccination in the 3rd trimester of pregnancy is an 
alternative measure for prevention of infant pertus-
sis, with the benefit of placental transfer of mater-
nal IgG to the infant. The vaccine effectiveness of 
the maternal antenatal vaccination program in the 
United Kingdom was estimated at 91% (84%–95% 
CI) for infants aged 3 months or less.28 Following 
the introduction of the program, significant reduc-
tions in infant pertussis mortality, numbers of 
confirmed cases and numbers of hospitalisations 
were reported.28 Adverse event surveillance has not 
detected any significant complications of maternal 
vaccination to date,29 but further investigation 
is required into the possibility of infant immune 
response blunting.28 Neonatal vaccination is an 
alternative possible means of infant pertussis con-
trol but similar concerns exist regarding immune 
blunting, requiring further study.30 More research 
is also required to determine whether these 
observed antibody responses translate into lower 
incidence of pertussis in infants.
This study is a retrospective review of the data 
collected as part of the routine surveillance of per-
tussis, meaning there are several limitations. The 
source of pertussis was unable to be identified in 
38.7% (n = 41) of cases who underwent enhanced 
surveillance. Previously published Australian 
studies on the source of infant pertussis have been 
unable to identify a source in 31%27 and 49%31 
respectively. This could be due to the source being 
an asymptomatic or mildly unwell household 
contact, or a contact from outside the household 
unknown to the notified case or caregiver under-
going interview. If previously vaccinated adults are 
more likely to experience mild or asymptomatic 
illness, the proportion of infant pertussis sources 
that were parents could be underestimated in 
studies relying on the recall of the notified case 
and epidemiologic linkage rather than laboratory 
testing. However, siblings were the most common 
source of infant pertussis in a recently published 
study, which performed laboratory testing on all 
household contacts in order to identify the source.24 
Another reason for the higher proportion of sib-
lings noted in the 2011–2012 period could be that 
as the epidemic progressed, clinician awareness 
of pertussis in younger children increased, with 
a concurrent increase in laboratory testing. If this 
were the case, previous reports of sibling sources 
of infant pertussis may have underestimated the 
true proportion of sources attributable to siblings. 
Regardless, there are still implications for infant 
pertussis prevention and control measures.
This study has shown that a rapid increase in 
notification rates in children at the peak of the 
2008–2012 epidemic in south metropolitan Perth 
was accompanied by a significant increase in sib-
lings as sources of pertussis in young infants. In 
the face of widespread vaccination with a less effec-
tive acellular pertussis vaccine, it seems likely that 
notification rates will remain high in children. 
Fully vaccinated siblings aged 2 and 3 years were 
the most important infant pertussis sources in the 
peak epidemic period of this study, suggesting that 
immunity may wane in this age group before the 
vaccine booster at 4 years . Even if it were possible 
to fully cocoon infants through a combination of 
parental vaccination and ensuring siblings were 
fully vaccinated, the possibility of transmission 
via breakthrough disease in siblings would persist. 
The risk of sibling transmission to infants would 
be significantly reduced through the addition of a 
pertussis vaccine booster at 18 months and mater-
nal antenatal vaccination, for which evidence of 
effectiveness at preventing pertussis in infants 3 
months of age or less is mounting.
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